✦ LIBER ✦

Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors

✍ Scribed by Vicram Gupta; E. Brad Thompson; Donna Stock-Novack; Sydney E. Salmon; H. Irving Pierce; John D. Bonnet; David Chilton; Jean Beckord

Book ID: 104986251
Publisher: Springer US
Year: 1994
Tongue: English
Weight: 631 KB
Volume: 12
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A159 Safety and Efficacy of Bortezomib i

A159 Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma

✍ Lalagianni, CE; Neokleous, N; Vadikoliou, C; Papalexandri, A; Apostolou, C; Salo 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Synthesis and Characterization of Nonste

Synthesis and Characterization of Nonsteroidal Glucocorticoid Receptor Modulators for Multiple Myeloma

✍ Hudson, Andrew R.; Roach, Steven L.; Higuchi, Robert I.; Phillips, Dean P.; Biss 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 414 KB

Continuous low-dose cyclophosphamide and

Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refractory multiple myeloma with severe heart failure

✍ Zhou, Fan; Ling, Chenhui; Guo, Lieping; Wei, Wei; Li, Lu; Shi, Haotian; Hou, Jia 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 813 KB

Efficacy and safety of fotemustine for t

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

✍ Silvia Mangiacavalli; GianMatteo Pica; Marzia Varettoni; Mario Lazzarino; Alessa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Combination of interferon and dexamethas

Combination of interferon and dexamethasone in refractory multiple myeloma

✍ J. F. San Miguel; M. Moro; J. Bladé; L. Guerras; J. Hernandez; R. Jimenez-Galind 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

The present pilot study was designed to analyse the efficacy and toxicity of the association of interferon (IFN) and dexamethasone (Dx) in 32 resistant and relapsed myeloma patients. Among the evaluable cases, 15 (68 per cent) responded to treatment (32 per cent achieved an objective respons4R-and 3

Efficacy of melphalan, arsenic trioxide,

Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma

✍ Borad, M J; Swift, R; Berenson, J R 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB